abt-199 has been researched along with baricitinib* in 1 studies
1 review(s) available for abt-199 and baricitinib
| Article | Year |
|---|---|
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections.
Topics: COVID-19; Drug Repositioning; HIV Infections; HIV-1; Humans; Janus Kinases; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT Transcription Factors; United States; Virus Latency | 2022 |